Zoetis Inc. $ZTS Holdings Lifted by Quantinno Capital Management LP

Quantinno Capital Management LP increased its position in shares of Zoetis Inc. (NYSE:ZTS) by 36.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 235,090 shares of the company’s stock after acquiring an additional 63,165 shares during the period. Quantinno Capital Management LP owned approximately 0.05% of Zoetis worth $36,662,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ZTS. Scott & Selber Inc. grew its stake in shares of Zoetis by 0.6% in the 2nd quarter. Scott & Selber Inc. now owns 11,652 shares of the company’s stock worth $1,817,000 after purchasing an additional 67 shares during the last quarter. North Star Asset Management Inc. boosted its holdings in Zoetis by 4.9% during the second quarter. North Star Asset Management Inc. now owns 1,441 shares of the company’s stock worth $225,000 after buying an additional 67 shares in the last quarter. Secure Asset Management LLC grew its position in Zoetis by 2.9% in the second quarter. Secure Asset Management LLC now owns 2,448 shares of the company’s stock worth $382,000 after buying an additional 68 shares during the last quarter. Moment Partners LLC increased its holdings in shares of Zoetis by 3.2% in the second quarter. Moment Partners LLC now owns 2,354 shares of the company’s stock valued at $367,000 after buying an additional 72 shares in the last quarter. Finally, CVA Family Office LLC increased its holdings in shares of Zoetis by 6.7% in the second quarter. CVA Family Office LLC now owns 1,173 shares of the company’s stock valued at $183,000 after buying an additional 74 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

ZTS has been the subject of several research reports. Stifel Nicolaus reduced their price objective on Zoetis from $140.00 to $130.00 and set a “hold” rating for the company in a research note on Tuesday, November 18th. Morgan Stanley reduced their target price on Zoetis from $211.00 to $175.00 and set an “overweight” rating for the company in a report on Monday, November 10th. JPMorgan Chase & Co. decreased their price target on Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. BTIG Research restated a “buy” rating and set a $160.00 price objective on shares of Zoetis in a report on Wednesday, December 3rd. Finally, HSBC set a $140.00 price objective on shares of Zoetis in a research note on Wednesday. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $164.20.

Zoetis Price Performance

NYSE ZTS opened at $117.54 on Friday. The company has a debt-to-equity ratio of 1.31, a current ratio of 3.64 and a quick ratio of 2.28. The firm has a market capitalization of $51.80 billion, a price-to-earnings ratio of 19.79, a price-to-earnings-growth ratio of 2.45 and a beta of 0.97. The company has a 50 day simple moving average of $131.51 and a 200-day simple moving average of $146.53. Zoetis Inc. has a 52-week low of $115.25 and a 52-week high of $181.85.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The firm had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.42 billion. During the same quarter in the prior year, the business earned $1.58 EPS. The company’s revenue for the quarter was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be issued a dividend of $0.53 per share. This is a positive change from Zoetis’s previous quarterly dividend of $0.50. This represents a $2.12 annualized dividend and a dividend yield of 1.8%. The ex-dividend date is Tuesday, January 20th. Zoetis’s dividend payout ratio is 33.67%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.